NeuroPace Inc
NPCE· Nasdaq
NPCENeuroPace Inc
Filed Nov 10, 2021 · 10-Q · 41 days after period end · 0001528287-21-000018
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $10.34M | $12.77M |
| Net Income | -$8.08M | -$4.13M |
| EPS Diluted | -$0.34 | -$19.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end
